ADARx Pharmaceuticals (ADRX) vs Perrigo (PRGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Perrigo is the larger company by market cap ($2.01 billion vs $1.85 billion), about 1.1 times the size. Perrigo pays a dividend yielding 7.97%, while ADARx Pharmaceuticals does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | PRGO |
|---|---|---|
| Share price | $17.33 | $14.55 |
| Market cap | $1.85B | $2.01B |
| 1-day change | -6.73% | +3.93% |
| YTD return | — | +4.53% |
| 1-year return | — | -32.89% |
| 5-year return | — | -67.46% |
| Forward P/E | — | 6.07 |
| EPS (TTM) | $-1.16 | $-12.28 |
| Dividend yield | 0.00% | 7.97% |
| Annual dividend | $0.00 | $1.16 |
| 52-week high | $23.21 | $22.02 |
| 52-week low | $17.20 | $9.23 |
| Distance from 52-week high | -25.33% | -33.92% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +13.40% |
| Average volume | 1.42M | 2.81M |
| Shares outstanding | 106.80M | 138.37M |
| Employees | 100 | 8,100 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Perrigo offers a meaningfully higher dividend yield (7.97% vs 0.00%).
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Perrigo
PRGO stock →Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 8,100 employees
ADRX vs PRGO FAQ
Which is bigger, ADARx Pharmaceuticals or Perrigo?
Perrigo (PRGO) is larger, with a market capitalization of $2.01B compared with $1.85B for ADARx Pharmaceuticals (ADRX).
Which pays a higher dividend, ADARx Pharmaceuticals or Perrigo?
Perrigo pays a dividend yielding 7.97%, while ADARx Pharmaceuticals does not currently pay a regular dividend.
Are ADARx Pharmaceuticals and Perrigo in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.